Patient-Centered HBV Educational Intervention Increased Knowledge and Improved HBV Monitoring and Management

November 8-12, 2019; Boston, Massachusetts
Nonrandomized, prospective study showed that a formal in-person education session resulted in sustained improvement in patients’ HBV knowledge, which was associated with downstream improvements in HBV monitoring and management.
Format: Microsoft PowerPoint (.ppt)
File Size: 156 KB
Released: November 16, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Related Content

Clinical Care Options (CCO) expert commentary on optimal timing for MTCT prophylaxis in pregnant women with chronic HBV

Joseph Ahn, MD, MS, MBA Released: July 13, 2021

Brief Clinical Care Options (CCO) presentation on AASLD guidance on treatment indications and treatment options for pregnant women with chronic HBV infection

Joseph Ahn, MD, MS, MBA Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 8, 2021 Expired: July 7, 2022

Clinical Care Options (CCO) expert commentary from Francesco Negro, MD, on managing coinfection with hepatitis B and hepatitis D viruses

Francesco Negro, MD Released: July 7, 2021

Clinical Care Options (CCO) 专家 Grace LH Wong 博士讨论了亚太地区在照护有 HCC 风险的 HBV 患者时的注意事项

Grace LH Wong, MD Released: June 24, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue